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Sunday, February 3, 2013 109aNCLX/NCKX6 is a recently identified gene responsible for a mitochondrial
Naþ-Ca2þ exchanger (NCXmit), a Ca
2þ extrusion system from mitochondria.
Although there have been accumulated data regarding roles of NCLX in
various kinds of cells, little is known about the roles in cardiomyocytes,
where repetitive Ca2þ transients occur and where a huge amount of ATP is
generated and utilized. In the present study, we carried out a combination
study of NCLX knockdown in spontaneously beating atrial cell line HL-1
and mathematical simulations. In HL-1 cells, NCLX knockdown by siRNA
reduced the protein expression by ~50%. A cytosolic Naþ-dependent mito-
chondrial Ca2þ efflux was decelerated by knocking down NCLX, confirming
that NCLX is a gene responsible for NCXmit in cardiomyocytes. Interestingly,
the cycle length of spontaneous Ca2þ oscillation and action potential generation
was significantly prolonged by knocking down NCLX. Detailed inspection
revealed that the rate of initial membrane depolarization and upstroke of
Ca2þ rise were markedly slower in the NCLX knockdown cells. Furthermore
Ca2þ content in sarcoplasmic reticulum (SR) was lower and SR Ca2þ reuptake
was slower in the NCLX knockdown cells. A mathematical model of HL-1 cells
showed that an automaticity of HL-1 cells are driven by a spontaneous Ca2þ
leak from SR, called ‘‘Ca2þ clock’’. Analyses using the model demonstrated
that blocking NCXmit reduced SR Ca
2þ content and SR Ca2þ leak, resulting
in the prolongation of beating rate. Taken together, the NCLX has an important
role in regulating cardiac automaticity by modulating ‘‘Ca2þ clock’’.
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Cardiac Naþ/Ca2þ exchanger (NCX) is the major Ca2þ efflux pathway on the
sarcolemmal membrane, counterbalancing Ca2þ influx via L-type Ca2þ current
during excitation-contraction coupling. In humans, guinea pigs and large
mammals, NCX removes 20-25% of total cytosolic Ca2þ during relaxation.
Therefore, altered NCX activity can modulate SR Ca2þ load and contribute
to abnormal Ca2þ handling and arrhythmias. Here, we demonstrate that: 1)
increased NADH inhibits NCX current (INCX); 2) NCX inhibition by NADH
is reactive oxygen species (ROS)-dependent; 3) the NADH-induced ROS is
independent of the mitochondrial electron transportation chain (ETC). INCX
was measured with whole cell patch-clamp at 37C after dialyzing the cell
with various pipette solutions. With 400mM NADH in the pipette solution,
INCX (at þ80mV) was reduced by 65% compared to control. Endogenously
elevated cytosolic NADH by lactate perfusion (1mM) also inhibited INCX by
79% (at þ80mV) compared to control without lactate perfusion. Measurement
of ROS revealed that increasing cytosolic NADH increased ROS accumulation.
The NADH-induced increase in ROS, as well as the inhibition of INCX, was
abrogated by co-dialysis with the H2O2 scavenger catalase, demonstrating
that NCX inhibition is mediated by ROS. Inhibition of ETC with rotenone
did not reverse NCX inhibition by NADH, whereas D diphenylene iodonium
(DPI), which inhibits both the ETC and NAD(P)H oxidases, abolished NCX
inhibition. Lactate also induced ROS production in cell suspensions in
a dose-dependent manner, which was inhibited by DPI but not by rotenone,
NaCN, or antimycin A. Our findings indicate that NCX is regulated by cyto-
solic NADH/NADþ redox status through a ROS-dependent mechanism involv-
ing NAD(P)H oxidase, a mechanism that is likely to have profound effects on
Ca2þ homeostasis under conditions that alter cytosolic pyridine nucleotide
redox state, for example, during ischemia-reperfusion, diabetes or chronic heart
failure.
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The glutamate transporter Excitatory Amino Acid Carrier 1 (EAAC1) cata-
lyzes rapid removal of glutamate, the major excitatory neurotransmitter in
the brain, from the extracellular space, preventing its accumulation to neuro-
toxic levels. Uphill substrate transport is coupled to co-transport of 3 Naþ,
1 Hþ, and counter-transport of 1 Kþ ion. The cation binding sites are yet to
be fully identified in this transporter. Here, we investigate the role of the
highly conserved D454 residue which is thought to contribute its side chain
to coordinating these cations. D454 was mutated to the non-ionizable aspara-
gine, as well as alanine. Kþ-induced relocation was impaired in EAAC1-
D454N, as the transporter no longer catalyzed forward transport. Our findingsindicated that Kþ could still bind to EAAC1-D454N, but with reduced appar-
ent affinity. Naþ/glutamate exchange was functional in EAAC1-D454N, as
demonstrated by the presence of transient currents following rapid glutamate
application and voltage jumps. In the D454A mutant, glutamate application
inhibited inward leak anion currents, and transient currents in response to
voltage jumps were abolished. This is consistent with Naþ binding being
impaired in this transporter. Kþ binding was also eliminated by the D454A
mutation. Although D454 is proposed to participate in Naþ binding, its pro-
tonation state is yet to be established. pKa calculations for the bacterial homo-
logue Gltph indicate that D405 (analogous to D454) is protonated at
physiological pH with a highly perturbed pKa in the range of 7.6 to >14.
Valences calculated using the Poison-Boltzmann equation for EAAC1 with
D454 protonated (0.45) were close in value to the experimental values ob-
tained for EAAC1-D54N (0.71) and EAAC1-WT (0.64). Together, our results
suggest that D454 is protonated under physiological conditions, and partici-
pates in Naþ as well as Kþ binding.
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In the crystal structure of the bacterial glutamate transporter homologue
GltPH, an L-aspartate and two Naþ ions are bound within the core of each sub-
unit and bordered by two hairpin loops: HP1 from the intracellular side and
HP2 from the extracellular side. Notably, in another crystal structure of GltPH
bound with L-threo-b-benzyloxyaspartate (L-TBOA), a non-transportable sub-
strate analogue, TBOA locks the transporter in an outward-facing conforma-
tion similar to the aspartate-bound complex, except that HP2 adopts an
‘‘open’’ conformation, exposing the substrate binding site to the extracellular
solution. This suggests that HP2 may serve as an extracellular gate. In addition,
our published voltage clamp fluorometry measurements show that there are
significant Naþ-dependent movements of HP2 preceding glutamate binding.
Here we use transition-metal FRET to study the movements of HP2 in human
glutamate transporter EAAT3 upon binding of substrate and inhibitor. Com-
pared to the classical FRET methods which have previously been used by
our lab to measure conformational changes in EAAT3 during the glutamate
transport cycle, the transition metal ion FRET pairs are smaller in size and
have a shorter R0 value than the traditional FRET pairs, which enables us to
measure distance change within a very short range to better study the confor-
mation change of HP2 during ion and substrate binding. By labeling the FRET
donor fluorophore and the transition metal ion acceptor at different positions of
glutamate transporter EAAT3, we measured intrasubunit distance changes of
the HP2 region in the presence of glutamate compared with in the presence
of L-TBOA.
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Human glutamate/aspartate transporters cotransport three Naþ and one Hþ ions
with the substrate and countertransport one Kþ ion. The archeal homolog
GltPh, which has a 36% sequence identity with the human transporters, trans-
ports aspartate and three sodium ions across the lipid membrane. We have pre-
viously performed Free Energy Perturbation (FEP) simulations of ligand
binding to GltPh in the extracellular(EC)-facing state, showing that the sub-
strate binds after two Naþ ions, with a strong water-mediated coupling between
the second sodium ion to bind (Na1) and the substrate. We have also performed
simulations and mutagenesis experiments to locate the binding site of the third
sodium ion (Na3), which could not be resolved in the crystal structure. More
recently, we have turned our focus to the intracellular(IC)-facing conformation
of GltPh. By running long unbiased simulations with different ligands bound to
the transporter, we were able to describe in details the gating mechanism and
point out the differences to the EC-facing state. The IC-facing FEP results dem-
onstrate that the unbinding of the ligands happens in a symmetrical manner,
with the ligands being released in the reverse order of their binding. The Na3
ion is, therefore, the first ligand to bind and the last to unbind. By means of
free energy calculations, Kramers’ theory and experiments, we are able to point
out the unbinding of the Na3 ion as the rate-limiting step in the transport mech-
anism. With all this information, we have built a homology model for a human
glutamate transporter (EAAT1) in different conformations, which can repro-
duce some of the differences observed in the transport mechanism of the human
and the bacterial transporters.
